Vol. 05 | 1/2 2019 Evidence Based Psychiatric Care Journal of the Italian Society of Psychiatry | Vol

Total Page:16

File Type:pdf, Size:1020Kb

Vol. 05 | 1/2 2019 Evidence Based Psychiatric Care Journal of the Italian Society of Psychiatry | Vol ESEC CAMPAGNA STAMPA RILASSANDO 210X280 RK-E-1803.pdf 1 22/03/18 09:37 IO SCELGO C DI STARE M Y BENE. CM MY CY CMY K Controlla l'ansia. Migliora la capacità di adattamento allo stress. Vol. 05 | 1/2_2019 Evidence based Psychiatric Care Journal of the Italian Society of Psychiatry | Vol. 05 | 1/2_2019 Editors-in-Chief Contents Enrico Zanalda Massimo Di Giannantonio Cognitive deficits and psychosocial functioning in schizophrenia: role of computer-assisted cognitive remediation Deputy Editors Cristiana Montemagni, Nadja Bracale, Silvio Bellino, Paola Bozzatello, Bernardo Carpiniello Enrico Zanalda, Mario Toye, Laura Canta, Paola Rocca 1 Giancarlo Cerveri Massimo Clerici Substance screening in a sample of “clubbers”: discrepancies between Domenico De Berardis self-reporting and urinalysis Guido Di Sciascio Luigia Piro, Giovanni Martinotti, Rita Santacroce, Chiara Vannini, Paola Rocca Chiara Montemitro, Raffaele Giorgetti, Fabrizio Schifano, Silvia Fraticelli, Antonio Vita Gaia Baroni, Massimo di Giannantonio 10 Commentary on the current Guidelines in Psychopharmacotherapy International Scientific Board Guido Di Sciascio, Clara Locatelli, Claudia Palumbo 17 Arango Celso, Madrid Fleischhacker Wolfgang, Innsbruck Towards Italian guidelines for the pharmacological treatment Fountoulakis Konstantinos N, Thessaloniki of Obsessive-Compulsive Disorder (OCD) in adults: a preliminary draft Grunze Heinz, Newcastle upon Tyne Umberto Albert, Bernardo Dell’Osso, Giuseppe Maina 21 Leucht Stefan, Munchen Rihmer Zoltan, Budapest Improved insight in first episode schizophrenic outpatients switching Jakovljevic Miro, Zagabria from oral to long-acting injectable aripiprazole: a cohort study Gorwood Philip, Paris Giuseppe Di Iorio, Maria Chiara Spano, Lucia Di Caprio, Demyttenaere Koen, Leuven Marco Lorusso, Andrea Miuli, Leonardo Carlucci, Giovanni Martinotti, Höschl Cyril, Praga Massimo di Giannantonio 30 Tiihonen Jari, Stockholm General and peculiar aspects of psychiatric certification Iris Bonfitto, Maria Rosaria Gigante, Giovanni Moniello, Leonardo Vitale, Antonello Bellomo 35 Editorial coordinator and secretary Lucia Castelli - [email protected] Tel. +39 050 3130224 - Fax +39 050 3130300 © Copyright by Pacini Editore Srl - Pisa Managing Editor Patrizia Alma Pacini Publisher Pacini Editore Srl via Gherardesca1 - 56121 Pisa, Italy Tel. +39 050 313011 - Fax +39 050 313000 www.pacinimedicina.it Journal registered at “Registro pubblico degli Operatori della Comunicazione” (Pacini Editore Srl registration n. 6269 - 29/8/2001) ISSN 2421-4469 (online) Registration in progress at the Tribunal of Pisa Information for Authors X Illustrations: a) send pictures in separate viations, and units of measure should con- les from text and tables; b) software and form to the standards set out in Science including editorial standards format: preferably send images in .TIFF or 1954;120:1078. for the preparation of .JPEG or .PDF format, resolution at least X Drugs should be referred to by their chem- manuscripts 300 dpi (100 x 150 mm). ical name; the commercial name should X The text must be written in English. be used only when absolutely unavoidable X The rst page of the manuscripts must (capitalising the rst letter of the product contain the names of the Authors and of name and giving the name of the pharma- the Institute or organisation to which each ceutical rm manufacturing the drug, town Author is affiliated; the name, mailing ad- and country). dress, telephone and fax numbers of the X Authors are required to correct and return Evidence-based Psychiatric Care, a quar- Author to whom correspondence and gal- galley proofs of their paper within 4 days terly on line, open access journal, is the Of- ley proofs should be sent; a set of key- of receipt. cial Journal of the Italian Society of Psy- words. chiatry (SIP). X Tables must be limited in number (the Categories of papers The journal publishes contributions in the same data should not be presented twice, Manuscripts will be organized in ve main eld of psychiatry in electronic format and in in both the text and tables), typewritten on categories. Namely: English, in the form of regular articles, re- separate pages, and numbered consecu- 1. Regular articles and reviews (which views, short articles, case reports, letters to tively with Roman numerals. In the text may also include invited articles). Text the editors and commentaries. and legend to the tables, Authors must length: 18.000 characters or more, with X The material submitted should not have use, in the exact order, the following sym- spaces, excluding summary, tables and/or been previously published, and should bols: *, †, ‡, §, **, ††, ‡‡ … gures and references. The text of regular not be under consideration (in whole or X Figures: please strictly follow the above- articles should be subdivided into the fol- in part) elsewhere; it must conform with mentioned instructions. lowing sections: Summary, Introduction, the regulations currently in force regard- X The references must be identied in the Materials and methods, Results, and Dis- ing research ethics. If an experiment on text by Arabic numbers in upper script and cussion and Conclusions. humans is described, a statement must listed at the end of the manuscript in the be included that the work was performed order of citation. In case of papers by more 2. Short articles: this space is dedicated to in accordance with the principles of the than 5 Authors, the rst 3 Authors should brief communications of clinical and ex- 1983 Declaration of Helsinki. The Authors be indicated, followed by et al. perimental data and to preliminary data are solely responsible for the statements X Journals should be cited according to the of ongoing research of particular interest. made in their paper, and must specify that abbreviations of Index Medicus. Text length: no more than 12.000 charac- consent has been obtained from patients ters, with spaces, including summary, g- taking part in the investigations and for ures and/or tables (no more than 4), and the reproduction of any photographs. For Examples of the correct format references (max 15). studies performed on laboratory animals, for bibliographic citations 3. Meet-the-expert: in which a well-reputed the authors must state that the relevant Journal articles: clinician and/or researcher will provide a national laws or institutional guidelines Schatzberg AF, Samson JA, Bloomingdale short evidence-based review related to an have been adhered to. KL, et al. Toward a biochemical classica- explicit issue. X Only papers that have been prepared in tion of depressive disorders, X: urinary cat- X Reviews, articles (both regular and short), strict conformity with the editorial norms echolamines, their metabolites, and D-type and meet-the-expert should contain a outlined herein will be considered for pub- scores in subgroups of depressive disor- window reporting the main implications for lication. Eventual acceptance is condition- ders. Arch Gen Psychiatry 1989;46:260-8. psychiatric care that derive from the data al upon a critical assessment by experts Books: presented in the publication. in the eld, the implementation of any Kaplan HI, Sadock BJ. Comprehensive text- X Reviews, articles (both regular and short) changes requested, and the nal decision book of Psychiatry. Baltimore: Williams & and meet-the-expert should have sum- of the Editor. Wilkins 1985. maries subdivided in the following sec- tions: Objectives, Materials and Methods, Conict of Interests. In the letter accom- Chapters from books or material from Results, and Conclusions. panying the article, Authors must declare conference proceedings: whether they obtained funds, or other forms Cloninger CR. Establishment of diagnostic va- 4. Case reports: in which original experienc- of personal or institutional nancing – or if lidity in psychiatric illness: Robins and Guze’s es related to individual or few subjects are they are under contract – from Companies method revisited. In: Robins LN, Barret JE, described. Text length: about 4.000-5000 whose products are mentioned in the article. editors. The validity of psychiatric diagnosis. characters, with spaces. Max 1 gure or This declaration will be treated by the Editor New York: Raven Press 1989, pp. 74-85. table and no more than 5 references. as condential, and will not be sent to the X Acknowledgements and the citation of 5. Letters to Editors and Comments con- referees. Accepted articles will be published any grants or other forms of nancial sup- cerning articles or reviews published in accompanied by a suitable declaration, stat- port should be provided at the end of the the Journal: text length: about 2.000-3.000 ing the source and nature of the nancing. paper, after the list of references. characters, with spaces. Max 1 gure and/ X Notes to the text, indicated by asterisks or or table and no more than 5 references. General instructions similar symbols, should appear at the bot- X Software and text: please save les in tom of the relevant page. The paper must be sent to: .DOC, .RTF or .DOCX format. X Mathematical terms and formulae, abbre- [email protected] Evidence based Psychiatric Care Journal of the Italian Society of Psychiatry Società Italiana di Psichiatria Cognitive deficits and psychosocial functioning in schizophrenia: role of computer-assisted cognitive remediation Cristiana Montemagni1, Nadja Bracale1, Silvio Bellino1, Paola Bozzatello1, Enrico Zanalda2, Mario Toye2, Laura Canta2, Paola Rocca1 1 Dipartimento di Neuroscienze “Rita Levi
Recommended publications
  • Recent Changes in Drug Abuse Scenario the Novel Psychoactive Substances (NPS) Phenomenon
    brain sciences Recent Changes in Drug Abuse Scenario The Novel Psychoactive Substances (NPS) Phenomenon Edited by Fabrizio Schifano Printed Edition of the Special Issue Published in Brain Sciences www.mdpi.com/journal/brainsci Recent Changes in Drug Abuse Scenario Recent Changes in Drug Abuse Scenario The Novel Psychoactive Substances (NPS) Phenomenon Special Issue Editor Fabrizio Schifano MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade Special Issue Editor Fabrizio Schifano University of Hertfordshire UK Editorial Office MDPI St. Alban-Anlage 66 4052 Basel, Switzerland This is a reprint of articles from the Special Issue published online in the open access journal Brain Sciences (ISSN 2076-3425) in 2018 (available at: https://www.mdpi.com/journal/brainsci/ special issues/drug abuse scenario) For citation purposes, cite each article independently as indicated on the article page online and as indicated below: LastName, A.A.; LastName, B.B.; LastName, C.C. Article Title. Journal Name Year, Article Number, Page Range. ISBN 978-3-03897-507-6 (Pbk) ISBN 978-3-03897-508-3 (PDF) c 2019 by the authors. Articles in this book are Open Access and distributed under the Creative Commons Attribution (CC BY) license, which allows users to download, copy and build upon published articles, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. The book as a whole is distributed by MDPI under the terms and conditions of the Creative Commons license CC BY-NC-ND. Contents About the Special Issue Editor ...................................... vii Fabrizio Schifano Recent Changes in Drug Abuse Scenarios: The New/Novel Psychoactive Substances (NPS) Phenomenon Reprinted from: Brain Sci.
    [Show full text]
  • New Psychoactive Substances (NPS)
    New Psychoactive Substances (NPS) LGC Quality Reference ISO 9001 ISO/IEC 17025 ISO Guide 34 materials GMP/GLP ISO 13485 2019 ISO/IEC 17043 Science for a safer world LGC offers the most extensive and up-to-date range of New LGC is a global leader in Psychoactive Substances (NPS) measurement standards, reference materials. reference materials, laboratory services and proficiency testing. With 2,600 professionals working When you make a decision using The challenge The LGC response We are the UK’s in 21 countries, our analytical our resources, you can be sure it’s designated National measurement and quality control based on precise, robust data. And New Psychoactive Substances In response to the ever-expanding LGC Standards provides the widest Measurement services are second-to-none. together, we’re creating fairer, safer, (NPS) continue to be identified, range of NPS being developed, LGC range of reference materials Institute for chemical more confident societies worldwide. and it appears that moves by the has produced a comprehensive available from any single supplier. and bioanalytical As a global leader, we provide the United Nations and by individual range of reference materials that We work closely with leading widest range of reference materials lgcstandards.com countries to control lists of meet the rapidly changing demands manufacturers to provide improved measurement. available from any single supplier. named NPS may be encouraging of the NPS landscape. Many of access to reference materials, the development of yet further these products are produced under with an increasingly large range variants to avoid these controls. the rigorous quality assurance of parameters, for laboratories standards set out in ISO Guide 34.
    [Show full text]
  • New Psychoactive Substances in Australia
    NEW PSYCHOACTIVE SUBSTANCES IN AUSTRALIA Rachel Sutherland BSocSc (Hons, Criminology) A thesis in fulfilment of the requirements for the degree of Doctor of Philosophy National Drug and Alcohol Research Centre School of Public Health and Community Medicine Faculty of Medicine University of New South Wales November 2018 i THESIS/DISSERTATION SHEET Surname/Family Name Sutherland Given Name/s Rachel Anne Abbreviation for degree as give in the University calendar PhD Faculty Medicine School School of Public Health and Community Medicine Thesis Title New psychoactive substances in Australia Abstract 350 words maximum: (PLEASE TYPE) Over the past decade, countries worldwide have observed the rapid emergence of substances collectively referred to as ‘new psychoactive substances’ (NPS). To date, hundreds of NPS have been identified; however, for the most part very little is known about these substances. The exponential growth of NPS, combined with uncertainty regarding potential harms, has generated considerable concern amongst policy makers and there is international consensus regarding the need for ongoing monitoring and research into the NPS market. However, much of the research conducted in this area originates from Europe and the United States, with Australian-specific studies relatively scarce. This thesis aimed to address this gap in Australian specific studies using two data sources: the 2013 National Drug Strategy Household Survey (NDSHS: a general population prevalence survey) and the Ecstasy and related Drugs Reporting System (EDRS: a national survey of high frequency psychostimulant consumers). Specifically, this thesis aimed to: 1) determine if there was a distinct group of exclusive Australian NPS consumers; 2) examine rates of use of different classes of NPS amongst people who use other illicit substances; 3) examine the motivations associated with NPS use; and 4) explore the purchasing and supply patterns of NPS consumers.
    [Show full text]
  • Artificial Intelligence to Detect Unknown Stimulants from Scientific Literature and Media Reports
    Food Control 130 (2021) 108360 Contents lists available at ScienceDirect Food Control journal homepage: www.elsevier.com/locate/foodcont Artificial intelligence to detect unknown stimulants from scientific literature and media reports Anand K. Gavai *, Yamine Bouzembrak, Leonieke M. van den Bulk, Ningjing Liu, Lennert F. D. van Overbeeke, Lukas J. van den Heuvel, Hans Mol, Hans J.P. Marvin Wageningen Food Safety Research (WFSR), Akkermaalsbos 2, 6708 WB, Wageningen, the Netherlands ARTICLE INFO ABSTRACT Keywords: The world market for food supplements is large and is driven by the claims of these products to, for example, Stimulants treat obesity, increase focus and alertness, decrease appetite, decrease the need for sleep or reduce impulsivity. Enhancers The use of illegal compounds in food supplements is a continuous threat, certainly because these compounds and Social media products have not been tested for safety by competent authorities. It is therefore of the utmost importance for the MedISys competent authorities to know when new products are being marketed and to warn users against potential health Word embedding Text mining risks. In this study, an approach is presented to detect new and unknown stimulants in food supplements using Emerging risk machine learning. Twenty new stimulants were identified from two different data sources, namely scientific literature applying word embedding on > 2 million abstracts and articles from formal and social media on the world wide web using text mining. The results show that the developed approach may be suitable to detect “unknowns” in the emerging risk identification activities performed by the competent authorities, which is currently a major hurdle.
    [Show full text]
  • Current Awareness in Clinical Toxicology Editors: Damian Ballam Msc and Allister Vale MD
    Current Awareness in Clinical Toxicology Editors: Damian Ballam MSc and Allister Vale MD December 2014 CONTENTS General toxicology 8 Metals 32 Management 17 Pesticides 35 Drugs 19 Chemical warfare 37 Chemical incidents & 27 Plants 38 pollution Chemicals 28 Animals 38 CURRENT AWARENESS PAPERS OF THE MONTH Position paper update: Whole bowel irrigation for gastrointestinal decontamination of overdose patients Thanacoody R, Caravati EM, Troutman WG, Höjer J, Benson BE, Hoppu K, Erdman A, Bedry R, Mégarbane B. Clin Toxicol 2014; online early: doi: 10.3109/15563650.2014.989326: Context A position paper on the use of whole bowel irrigation (WBI) was first published in 1997 by the American Academy of Clinical Toxicology (AACT) and the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) and updated in 2004. The aims of this paper are to briefly summarize the content of the 2004 Position Paper and to present any new data and recommendations. Methods A systematic review of the literature from January 2003 to February 28, 2013 was conducted using multiple online databases for articles concerning WBI for gastrointestinal decontamination. An evidence table was created for applicable articles. The authors produced the initial draft that was reviewed by AACT and EAPCCT. Current Awareness in Clinical Toxicology is produced monthly for the American Academy of Clinical Toxicology by the Birmingham Unit of the UK National Poisons Information Service, with contributions from the Cardiff, Edinburgh, and Newcastle Units. The NPIS is commissioned by Public Health England 2 Results The literature search produced 60 articles with the possibility of applicable human data. Based mainly on volunteer studies, WBI can be considered for potentially toxic ingestions of sustained-release or enteric-coated drugs particularly for those patients presenting later than 2 h after drug ingestion when activated charcoal is less effective.
    [Show full text]
  • Controlled Substances List (Adopted by Alabama State Board of Health on January 20, 2021, Effective January 20, 2021)
    1 Controlled Substances List (Adopted by Alabama State Board of Health on January 20, 2021, effective January 20, 2021) Schedule I (a) Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it. (b) Opiates. Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation (for purposes of 3-methylthiofentanyl only, the term isomer includes the optical and geometric isomers): (1) Acetyl-alpha-methylfentanyl (N-[1-[1-methyl-2-phenethyl]-4-piperidinyl]- N-phenylacetamide -------------------------------------------------------------------- 9815 (Federal Control Nov. 29, 1985; State Dec. 29, 1985) (2) Acetylmethadol ------------------------------------------------------------------------- 9601 (3) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl] benzamide -------------------------------------------------------------------------------- 9551 Federal Control May 16, 2016; State June 15, 2016 (4) Allylprodine ----------------------------------------------------------------------------- 9602 (5) Alphacetylmethadol --------------------------------------------------------------------- 9603 (6) Alphameprodine
    [Show full text]
  • Qualitative Detection of Selected Designer Drugs and Relevant
    Florida International University FIU Digital Commons FIU Electronic Theses and Dissertations University Graduate School 7-14-2016 Qualitative Detection of Selected Designer Drugs and Relevant Metabolites in Environmental Water Samples Marley Pruyn Florida International University, [email protected] DOI: 10.25148/etd.FIDC000751 Follow this and additional works at: https://digitalcommons.fiu.edu/etd Part of the Analytical Chemistry Commons, and the Other Chemistry Commons Recommended Citation Pruyn, Marley, "Qualitative Detection of Selected Designer Drugs and Relevant Metabolites in Environmental Water Samples" (2016). FIU Electronic Theses and Dissertations. 2571. https://digitalcommons.fiu.edu/etd/2571 This work is brought to you for free and open access by the University Graduate School at FIU Digital Commons. It has been accepted for inclusion in FIU Electronic Theses and Dissertations by an authorized administrator of FIU Digital Commons. For more information, please contact [email protected]. FLORIDA INTERNATIONAL UNIVERSITY Miami, Florida QUALITATIVE DETECTION OF SELECTED DESIGNER DRUGS AND RELEVANT METABOLITES IN ENVIRONMENTAL WATER SAMPLES A thesis submitted in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE in CHEMISTRY by Marley Pruyn 2016 To: Dean Michael R. Heithaus choose the name of dean of your college/school College of Arts, Sciences and Education choose the name of your college/school This thesis, written by Marley Pruyn, and entitled Qualitative Detection of Selected Designer Drugs and Relevant Metabolites in Environmental Water Samples, having been approved in respect to style and intellectual content, is referred to you for judgment. We have read this thesis and recommend that it be approved. _______________________________________ Jose Almirall _______________________________________ Anthony DeCaprio _______________________________________ Piero Gardinali, Major Professor Date of Defense: July 14, 2016 The thesis of Marley Pruyn is approved.
    [Show full text]
  • A Magyarországon Megjelent, a Kábítószer És Kábítószer-Függőség
    A Magyarországon megjelent, a Kábítószer és Kábítószer-függ őség Európai Megfigyel ő Központjának Korai Jelz őrendszerébe (EMCDDA EWS) 2005 óta bejelentett ellenőrzött anyagok büntet őjogi vonatkozású besorolása Név Egyéb nevek* Jogi státusz ( a 2015. július 11-i állapot szerint ) Megjegyzések** 1-nafiron nafiron 2012. április 3-tól új pszichoaktív anyag, UP jegyzék 5. felsorolásában szerepl ő anyag 2015. január 1-t ől büntet őjogilag kábítószernek 1998. évi XXV. törvény mellékletének "A" jegyzéke min ősül 25B-N(BOMe)2 2012. április 3-tól új pszichoaktív anyag UP jegyzék 4. szerkezeti leírásának megfelel ő anyag 25B-NBOMe 2012. április 3-tól új pszichoaktív anyag UP jegyzék 4. szerkezeti leírásának megfelel ő anyag 25C-NBOMe 2012. április 3-tól új pszichoaktív anyag UP jegyzék 4. szerkezeti leírásának megfelel ő anyag 25I-NBF 2015. július 11-t ől új pszichoaktív anyag UP jegyzék 5. felsorolásában szerepl ő anyag 25I-NBOMe 2012. április 3-tól új pszichoaktív anyag, UP jegyzék 4. szerkezeti leírásának megfelel ő anyag 2015. január 1-t ől büntet őjogilag kábítószernek 1998. évi XXV. törvény mellékletének "A" jegyzéke min ősül 2C-C 2012. április 3-tól új pszichoaktív anyag UP jegyzék 4. szerkezeti leírásának megfelel ő anyag 2C-D 2012. április 3-tól új pszichoaktív anyag UP jegyzék 4. szerkezeti leírásának megfelel ő anyag 2C-E 2012. április 3-tól új pszichoaktív anyag UP jegyzék 4. szerkezeti leírásának megfelel ő anyag 2C-I büntet őjogilag kábítószernek min ősül 1998. évi XXV. törvény mellékletének "A" jegyzéke 2C-P 2012. április 3-tól új pszichoaktív anyag UP jegyzék 4. szerkezeti leírásának megfelel ő anyag 2C-TFM 2012.
    [Show full text]
  • 1 SB333 2 158141-2 3 by Senator Orr 4 RFD: Judiciary 5 First Read: 11-FEB-14
    1 SB333 2 158141-2 3 By Senator Orr 4 RFD: Judiciary 5 First Read: 11-FEB-14 Page 0 SB333 1 SB333 2 3 4 ENROLLED, An Act, 5 Relating to Schedule I controlled substances; to 6 amend Sections 13A-12-231 and 20-2-23, Code of Alabama 1975, 7 to increase the requisite weight for trafficking in controlled 8 substance analogues; to include additional synthetic 9 controlled substances and analogues to the Schedule I 10 controlled substances list; and in connection therewith would 11 have as its purpose or effect the requirement of a new or 12 increased expenditure of local funds within the meaning of 13 Amendment 621 of the Constitution of Alabama of 1901, now 14 appearing as Section 111.05 of the Official Recompilation of 15 the Constitution of Alabama of 1901, as amended. 16 BE IT ENACTED BY THE LEGISLATURE OF ALABAMA: 17 Section 1. This act shall be known and may be cited 18 as Landon's Law. 19 Section 2. Sections 13A-12-231 and 20-2-23, Code of 20 Alabama 1975, are amended to read as follows: 21 "§13A-12-231. 22 "Except as authorized in Chapter 2, Title 20: 23 "(1) Any person who knowingly sells, manufactures, 24 delivers, or brings into this state, or who is knowingly in 25 actual or constructive possession of, in excess of one kilo or Page 1 SB333 1 2.2 pounds of any part of the plant of the genus Cannabis, 2 whether growing or not, the seeds thereof, the resin extracted 3 from any part of the plant, and every compound, manufacture, 4 salt, derivative, mixture, or preparation of the plant, its 5 seeds, or resin including the completely defoliated
    [Show full text]
  • Novel Psychoactive Substances: Implications for UK Drugs Policy
    Novel Psychoactive Substances: Implications for UK Drugs Policy A thesis submitted to the University of Manchester for the degree of PhD in the Faculty of Humanities 2016 Joseph Ritchie School of Law Contents List of Tables.....................................................................................................................6 List of Figures....................................................................................................................7 Thesis Abstract ..................................................................................................................8 Declaration ........................................................................................................................9 Statement of Copyright....................................................................................................10 Acknowledgements .........................................................................................................11 Dedication........................................................................................................................11 Chapter 1: Introduction....................................................................................................12 Introduction and Thesis Structure ...................................................................................12 Background......................................................................................................................16 NPS, Problematization and the Production of ‘Policy Problems’...................................19
    [Show full text]
  • Color Tests and Analytical Difficulties with Emerging Drugs of Abuse
    Jeremiah Morris Johnson County Sheriff’s Office Criminalistics Laboratory OH OH OH OH H H O CP-47,497 HU-210 OH O Tetrahydrocannabinol O O N JWH-073 N JWH-018 2 Nothing suitable published so far No color with Duquenois-Levine O Structural interferences para-Dimethylaminobenzaldehyde N reagent (Ehrlich’s) Test with glutaconic aldehyde Vegetation interferences Fast Blue B and 2B reagents Sulfuric based color tests UV fluorescence of indole nucleus Color test for aromatic carbonyls 3 Most cannabinoids react with Liebermann’s Reference Cannabinoid Chemical Class Source Color JWH-307 Naphthoylpyrrole Reference Collection Dark Yellow AB-001 Adamantoyl indole Reference Collection Dark Yellow CB-13 Dinaphthlyene methanone Reference Collection Dark Green JTE-907 1,2-Dihydroquinoline-3- Reference Collection Black (Bubbling) carboxamide UR-144 Tetramethylcyclopropanoylindole Reference Collection Dark Red URB597 FAAH inhibitor Reference Collection Yellow-Brown URB602 FAAH inhibitor Reference Collection Dark Brown URB754 FAAH inhibitor Reference Collection Light Brown AM-1248 Adamantoyl indole Reference Collection Dark Yellow AB-034 Tetramethylcyclopropanoylindole Reference Collection Red-Orange>Dark Red A-796, 260 Tetramethylcyclopropanoylindole Reference Collection Red-Orange>Dark Red A-834-735 Tetramethylcyclopropanoylindole Reference Collection Red-Orange>Dark Red FUR-144 Tetramethylcyclopropanoylindole Reference Collection Dark Red AKB48 Adamantyl amidoindazole Reference Collection No color change JWH-073 Naphthoylindole Cayman Chemical
    [Show full text]
  • Finding Unknown Stimulants Applied in Food Supplements Using Arti Cial
    Finding unknown stimulants applied in food supplements using Articial Intelligence Anand Gavai ( [email protected] ) Wageningen Food Safety Research (WFSR) https://orcid.org/0000-0002-4738-190X Yamine Bouzembrak Wageningen Food Safety Research (WFSR) Leonieke Bulk Wageningen Food Safety Research (WFSR) Ningjing Liu Wageningen Food Safety Research (WFSR) Lennert van Overbeeke Wageningen Food Safety Research (WFSR) Lucas Heuvel Wageningen Food Safety Research (WFSR) Hans Mol Wageningen Food Safety Research (WFSR) Hans Marvin Wageningen University and Research (WUR) Article Keywords: Stimulants, Enhancers, Social media, MedISys, Word Embedding, Text Mining, Emerging Risk. Posted Date: April 21st, 2021 DOI: https://doi.org/10.21203/rs.3.rs-447092/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Version of Record: A version of this preprint was published on June 22nd, 2021. See the published version at https://doi.org/10.1016/j.foodcont.2021.108360. Page 1/21 Abstract The world market for food supplements is large and is driven by the claims of these products to, for example, treat obesity, increase focus and alertness, decrease appetite, decrease the need for sleep or reduce impulsivity. The use of illegal compounds in food supplements is a continuous threat, certainly because these compounds and products have not been tested for safety by competent authorities. It is therefore of the utmost importance for the competent authorities to know when new products are being marketed and to warn users against potential health risks. In this study we present an approach to detect new and unknown stimulants in food supplements using machine learning.
    [Show full text]